GPT-Rosalind (OpenAI) vs Perplexity Computer

Which one should you pick? Here's the full breakdown.

GPT-Rosalind (OpenAI)

C
6.8/10

OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)

Our Pick

Perplexity Computer

A
8.4/10

Perplexity's general-purpose digital worker -- operates real software like you do, runs for hours or months, routes sub-tasks to Opus, Gemini, GPT-5.2, Grok, and Veo 3.1

Powered by Claude Opus 4.6 (core reasoning) + Model Council

CategoryGPT-Rosalind (OpenAI)Perplexity Computer
Ease of Use3.08.5
Output Quality9.09.0
Value7.06.5
Features8.09.5
Overall6.88.4

Pricing Comparison

FeatureGPT-Rosalind (OpenAI)Perplexity Computer
Free TierNoNo
Starting PriceInvite only$20

Which Should You Pick?

Pick GPT-Rosalind (OpenAI) if...

Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Visit GPT-Rosalind (OpenAI)

Pick Perplexity Computer if...

  • Easier to use (8.5 vs 3)
  • More features (9.5 vs 8)

Professionals and small teams who will burn $200/month worth of research, drafting, and multi-step workflow time -- consultants, researchers, analysts, founders. Especially strong if you want frontier models across text, video, and images in one agent without stitching APIs together. The right pick if infrastructure is a non-starter and quality ceiling matters more than cost.

Visit Perplexity Computer

Our Verdict

Perplexity Computer is the clear winner here with 8.4/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Perplexity Computer outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.